The Janeway Lab at Dana-Farber Cancer Institute led by @janeway_MD Focusing on genomics, precision oncology, and pediatric bone sarcomas
Joined January 2022
- Tweets37
- Following189
- Followers260
- Likes86
The Janeway Lab retweeted
New work from the @JanewayLab reporting on a pediatric cancer patient cohort sequenced @DanaFarber with 95! different cancer diagnoses. So important to share data to learn about @RareCancer rdcu.be/dNt1d
The Janeway Lab retweeted
It is the anniversary of our patient partnered osteosarcoma project — osproject.org — creating a clinico-genomic database for the research community to drive discovery. Patients enroll online. Consider referring your patients during #childhoodcancerawareness month
The Janeway Lab retweeted
So happy to see work done by Maeve Smart @JanewayLab about Covid-19 infection in pediatric cancer patients at #ASCO2023
The Janeway Lab retweeted
Excited to present on our patient partnered research on osteosarcoma and leiomyosarcoma next month!!
This Post is from an account that no longer exists. Learn more
The Janeway Lab retweeted
Pediatric Cancer Working Group session
#AACR2023 #osteosarcoma
@OSInstitute @janeway_MD @huntsmancancer @DanaFarber #MIBagents #MakeItBetter
We are excited to share our recent publication in
@JCOPO_ASCO, "FGFR Oncogenic Alterations in Sequenced Pediatric Solid and Brain Tumors Suggest FGFR Is a Relevant Molecular Target in Childhood Cancer.” Thank you to all our collaborators and co-authors!
ascopubs.org/doi/abs/10.1200…
The Janeway Lab retweeted
86% of pediatric cancer patients w extracranial solid tumors have genomic alterations that potentially impact clinical care. Important somatic sequencing results from the GAIN/iCAT2 study.Beautiful work @AlannaChurch_MD @janeway_MD @JanewayLab et al. go.nature.com/3BP9c40
The Janeway Lab retweeted
A new study published in @NatureMedicine found that 86 percent of extracranial solid tumors in pediatric patients had genomic alterations. Learn more about the findings from lead author Dr. Alanna Church @AlannaChurch_MD in @HealthDayTweets. bit.ly/3PSbW4y.
The Janeway Lab retweeted
An interim report from the GAIN/iCat2 study shows that molecular profiling of pediatric solid malignancies clarifies diagnostic classifications and provides opportunities for matched targeted therapy @janeway_MD @JanewayLab @AlannaChurch_MD
nature.com/articles/s41591-0…
The Janeway Lab retweeted
Getting ready for my presentation 👩💼this afternoon at 3p ET. Please join us for this free webinar to get to know @AgentsMIB and to hear about how molecular profiling is helping #ChildhoodCancer
The @NatureMedicine paper is available here: rdcu.be/cQgmj
🔬OsteoBites @AlannaChurch_MD to discuss study recently published in @NatureMedicine with @janeway_MD & many others, demonstrating the clinical utility of molecular tumor profiling for children with cancer.
Join in the discussion: bit.ly/3yIwcja
An incredibly gifted writer, a bright soul, and an ARMS warrior, Kasey Altman. Rest in the sweetest peace.
The Janeway Lab retweeted
Excited #CCDI Molecular characterization initiative of @COGorg now enrolling #sarcoma! Molecular tumor profiling of enrolled patients @nationwidekids is similar DNA and RNA sequencing as our study just published in @NatureMedicine showing clinical benefit:
nature.com/articles/s41591-0…
The Janeway Lab retweeted
All of the data is available in the supplement for the manuscript. The fusions in this cohort are DNAJB1::PRKACA in fibrolamellar carcinoma, an entity beautifully described by @DrSolidTumors here: sciencedirect.com/science/ar…
The Janeway Lab retweeted
It has been great working with @AlannaChurch_MD , colleagues from 16 institutions, and patients and families on this report from the GAIN consortium/iCat2 study addressing the clinical impact of targeted NGS in pediatric solid tumors. Collaboration is key for rare cancers!
The Janeway Lab retweeted
An interim report from the GAIN/iCat2 study shows that molecular profiling of pediatric solid malignancies clarifies diagnostic classifications and provides opportunities for matched targeted therapy @janeway_MD @JanewayLab, @AlannaChurch_MD
nature.com/articles/s41591-0…
The Janeway Lab retweeted
Congratulations, @AlannaChurch_MD and all! Beautiful and important work that showcases the emerging importance of molecular pathology.